{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:27:06Z","timestamp":1707179226109},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11102-023-01379-4","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T09:02:15Z","timestamp":1704272535000},"page":"3-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pituitary: hic manebimus optime"],"prefix":"10.1007","volume":"27","author":[{"given":"Andrea","family":"Giustina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"1379_CR1","unstructured":"Melmed S A fond farewell Pituitary in press"},{"key":"1379_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12020-011-9448-3","volume":"39","author":"A Giustina","year":"2011","unstructured":"Giustina A (2011) Quo Vadis Endocrine 39:101\u2013103. https:\/\/doi.org\/10.1007\/s12020-011-9448-3","journal-title":"Quo Vadis Endocrine"},{"issue":"3","key":"1379_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12020-018-1790-2","volume":"62","author":"A Giustina","year":"2018","unstructured":"Giustina A (2018) Fabula (non) acta est\u2026 endocrine. Endocrine 62(3):503\u2013505. https:\/\/doi.org\/10.1007\/s12020-018-1790-2. PMID: 30382553","journal-title":"Endocrine"},{"issue":"3","key":"1379_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11102-020-01041-3","volume":"23","author":"L di Filippo","year":"2020","unstructured":"di Filippo L, Doga M, Resmini E, Giustina A (2020) Hyperprolactinemia and bone. Pituitary 23(3):314\u2013321. https:\/\/doi.org\/10.1007\/s11102-020-01041-3. PMID: 32219718","journal-title":"Pituitary"},{"issue":"4","key":"1379_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678. https:\/\/doi.org\/10.1007\/s11154-020-09588-z. Epub 2020 Sep 10. PMID: 32914330; PMCID: PMC7942783","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"1379_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A, Pituitary, Society, Expert Group on Pituitary Tumors (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489\u2013498 Erratum in: Pituitary. 2018;: PMID: 28884415; PMCID: PMC5606938","journal-title":"Pituitary"},{"issue":"5","key":"1379_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, Strasburger C, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583\u2013596. https:\/\/doi.org\/10.1007\/s11102-023-01345-0. Epub 2023 Aug 28. PMID: 37640885; PMCID: PMC10539196","journal-title":"Pituitary"},{"issue":"3","key":"1379_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11102-020-01028-0","volume":"23","author":"G Tulipano","year":"2020","unstructured":"Tulipano G, Giustina A (2020) Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary Tumor cells. Pituitary 23(3):223\u2013231. https:\/\/doi.org\/10.1007\/s11102-020-01028-0. PMID: 31997055","journal-title":"Pituitary"},{"key":"1379_CR9","doi-asserted-by":"publisher","unstructured":"Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, Bianchi I, Cocchi D, Giustina A (2007) Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125. Pituitary. ;10(3):267\u2009\u2013\u200974. https:\/\/doi.org\/10.1007\/s11102-007-0054-6. PMID: 17587180","DOI":"10.1007\/s11102-007-0054-6"},{"key":"1379_CR10","doi-asserted-by":"publisher","unstructured":"Tulipano G, Faggi L, Cacciamali A, Spinello M, Cocchi D, Giustina A (2014) Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro. Pituitary 17(3):203-209. https:\/\/doi.org\/10.1007\/s11102-013-0488-y. PMID: 23649927","DOI":"10.1007\/s11102-013-0488-y"},{"issue":"3","key":"1379_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11102-007-0037-7","volume":"10","author":"L De Marinis","year":"2007","unstructured":"De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, Mazziotti G, Pontecorvi A, Giustina A (2007) Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. Pituitary 10(3):227\u2013232. https:\/\/doi.org\/10.1007\/s11102-007-0037-7. PMID: 17484056","journal-title":"Pituitary"},{"key":"1379_CR12","doi-asserted-by":"publisher","unstructured":"Giustina A, Boni E, Romanelli G, Grassi V, Giustina G (1995) Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 75(15):1042-7. https:\/\/doi.org\/10.1016\/s0002-9149(99)80721-8. PMID: 7747686","DOI":"10.1016\/s0002-9149(99)80721-8"},{"key":"1379_CR13","doi-asserted-by":"publisher","unstructured":"De Marinis L, Bianchi A, Mazziotti G, Mettimano M, Milardi D, Fusco A, Cimino V, Maira G, Pontecorvi A, Giustina A (2008) The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 11(1):13\u201320. https:\/\/doi.org\/10.1007\/s11102-007-0062-6. PMID: 17987389","DOI":"10.1007\/s11102-007-0062-6"},{"key":"1379_CR14","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299\u2013306. https:\/\/doi.org\/10.1007\/s11102-011-0293-4. PMID: 21301967","DOI":"10.1007\/s11102-011-0293-4"},{"issue":"6","key":"1379_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010. PMID: 35395078; PMCID: PMC9695123","journal-title":"Endocr Rev"},{"key":"1379_CR16","doi-asserted-by":"publisher","unstructured":"Gola M, Bonadonna S, Mazziotti G, Amato G, Giustina A (2006) Resistance to somatostatin analogs in acromegaly: an evolving concept? J Endocrinol Invest 29(1):86\u201393. https:\/\/doi.org\/10.1007\/BF03349183. PMID: 16553040","DOI":"10.1007\/BF03349183"},{"issue":"2","key":"1379_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12020-023-03317-7","volume":"80","author":"A Giustina","year":"2023","unstructured":"Giustina A, di Filippo L, Uygur MM, Frara S (2023) Modern approach to resistant acromegaly. Endocrine 80(2):303\u2013307. https:\/\/doi.org\/10.1007\/s12020-023-03317-7. Epub 2023 Feb 15. PMID: 36790521","journal-title":"Endocrine"},{"issue":"10","key":"1379_CR18","doi-asserted-by":"publisher","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","volume":"105","author":"SL Samson","year":"2020","unstructured":"Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S (2020) Maintenance of Acromegaly Control in patients switching from Injectable somatostatin receptor ligands to oral Octreotide. J Clin Endocrinol Metab 105(10):e3785\u2013e3797. https:\/\/doi.org\/10.1210\/clinem\/dgaa526. PMID: 32882036; PMCID: PMC7470473","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1379_CR19","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1080\/14656566.2016.1199687","volume":"17","author":"F Maffezzoni","year":"2016","unstructured":"Maffezzoni F, Formenti AM, Mazziotti G, Frara S, Giustina A (2016) Current and future medical treatments for patients with acromegaly. Expert Opin Pharmacother 17(12):1631\u20131642. https:\/\/doi.org\/10.1080\/14656566.2016.1199687. Epub 2016 Jun 28. PMID: 27352098","journal-title":"Expert Opin Pharmacother"},{"key":"1379_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-09-0372","volume":"161","author":"A Giustina","year":"2009","unstructured":"Giustina A, Bonadonna S, Bugari G, Colao A, Cozzi R, Cannavo S, de Marinis L, Degli Uberti E, Bogazzi F, Mazziotti G, Minuto F, Montini M, Ghigo E (2009) High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol 161:331\u2013338","journal-title":"Eur J Endocrinol"},{"key":"1379_CR21","doi-asserted-by":"publisher","unstructured":"Giustina A, Mazziotti G, Cannav\u00f2 S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E (2017) High-dose and high-frequency lanreotide autogel in acromegaly: a randomized, multicenter study. J Clin Endocrinol Metab. ;102(7):2454\u20132464. https:\/\/doi.org\/10.1210\/jc.2017-00142. PMID: 28419317","DOI":"10.1210\/jc.2017-00142"},{"issue":"2","key":"1379_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11154-021-09672-y","volume":"23","author":"S Frara","year":"2022","unstructured":"Frara S, Loli P, Allora A, Santini C, di Filippo L, Mortini P, Fleseriu M, Giustina A (2022) COVID-19 and hypopituitarism. Rev Endocr Metab Disord 23(2):215\u2013231. https:\/\/doi.org\/10.1007\/s11154-021-09672-y. Epub 2021 Aug 13. PMID: 34387832; PMCID: PMC8363093","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"1379_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11102-021-01148-1","volume":"24","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, Castellino L, di Filippo L, Loli P, Giustina A (2021) COVID-19 and the pituitary. Pituitary 24(3):465\u2013481. https:\/\/doi.org\/10.1007\/s11102-021-01148-1. Epub 2021 May 3. PMID: 33939057; PMCID: PMC8089131","journal-title":"Pituitary"},{"issue":"2","key":"1379_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12020-021-02734-w","volume":"72","author":"M Puig-Domingo","year":"2021","unstructured":"Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A (2021) COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2):301\u2013316. https:\/\/doi.org\/10.1007\/s12020-021-02734-w. Epub 2021 May 8. PMID: 33963516; PMCID: PMC8105151","journal-title":"Endocrine"},{"issue":"3","key":"1379_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly Complications. Pituitary 16(3):294\u2013302. https:\/\/doi.org\/10.1007\/s11102-012-0420-x. PMID: 22903574; PMCID: PMC3730092","journal-title":"Pituitary"},{"issue":"1","key":"1379_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, Molitch ME, Samson SL, Strasburger CJ, van der Lely AJ, Melmed S (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1\u201313. https:\/\/doi.org\/10.1007\/s11102-020-01091-7. Epub 2020 Oct 20. PMID: 33079318; PMCID: PMC7864830","journal-title":"Pituitary"},{"key":"1379_CR27","doi-asserted-by":"publisher","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group (2023) Consensus on criteria for acromegaly diagnosis and remission. Pituit. https:\/\/doi.org\/10.1007\/s11102-023-01360-1. Epub ahead of print. Erratum in: Pituitary. 2023;: PMID: 37923946.","DOI":"10.1007\/s11102-023-01360-1"},{"key":"1379_CR28","doi-asserted-by":"publisher","unstructured":"Giustina A, Bronstein MD, Casanueva FF, Chanson P, Ghigo E, Ho KK, Klibanski A, Lamberts S, Trainer P, Melmed S (2011) Current management practices for acromegaly: an international survey. Pituitary 14(2):125\u2013133. https:\/\/doi.org\/10.1007\/s11102-010-0269-9. PMID: 21063787","DOI":"10.1007\/s11102-010-0269-9"},{"issue":"5","key":"1379_CR29","doi-asserted-by":"publisher","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","volume":"7","author":"A Giustina","year":"2012","unstructured":"Giustina A, Mazziotti G, Torri V, Spinello M, Floriani I, Melmed S (2012) Meta-analysis on the effects of octreotide on Tumor mass in acromegaly. PLoS ONE 7(5):e36411. https:\/\/doi.org\/10.1371\/journal.pone.0036411. Epub 2012 May 4. PMID: 22574156; PMCID: PMC3344864","journal-title":"PLoS ONE"},{"key":"1379_CR30","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384\u2009\u2013\u2009394. https:\/\/doi.org\/10.1210\/jc.2014-2937. Epub 2014 Nov 3. PMID: 25365312","DOI":"10.1210\/jc.2014-2937"},{"key":"1379_CR31","doi-asserted-by":"publisher","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2019) A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22(6):569\u2013573. https:\/\/doi.org\/10.1007\/s11102-019-00988-2. PMID: 31571098","DOI":"10.1007\/s11102-019-00988-2"},{"key":"1379_CR32","doi-asserted-by":"publisher","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2020) The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 23(4):476\u2013477. https:\/\/doi.org\/10.1007\/s11102-019-01027-w. PMID: 31912348","DOI":"10.1007\/s11102-019-01027-w"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01379-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01379-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:15:23Z","timestamp":1707124523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01379-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01379-4","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"23 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}